Clinic for Horses, University of Veterinary Medicine, Hannover, Germany.
Institute for Anatomy, University of Veterinary Medicine, Hannover, Germany.
Equine Vet J. 2021 Jan;53(1):125-133. doi: 10.1111/evj.13251. Epub 2020 Mar 24.
Pharmacological preconditioning of dexmedetomidine on small intestinal ischaemia/reperfusion injury has been reported in different animal models including horses.
The objective was to assess if xylazine and lidocaine have a preconditioning effect in an experimental model of equine jejunal ischaemia.
Terminal in vivo experiment.
Ten horses under general anaesthesia were either preconditioned with xylazine (group X; n = 5) or lidocaine (group L; n = 5). A historical untreated control group (group C; n = 5) was used for comparison. An established experimental model of equine jejunal ischaemia was applied, and intestinal samples were taken pre-ischaemia, after ischaemia and following reperfusion. Histomorphological examination was performed based on a modified Chiu score. Immunohistochemical staining for cleaved caspase-3, TUNEL and calprotectin was performed, and positive cell counts were expressed in cells/mm .
There was no progression of histomorphological mucosal injury from ischaemia to reperfusion, and there were no differences in histomorphology between the groups. After ischaemia, group X had significantly less caspase-positive cells compared to the control group with a median difference of 227% (P = .01). After reperfusion, group X exhibited significantly lower calprotectin-positive cell counts compared to the control group, with a median difference of 6.8 cells/mm in the mucosa and 44 cells in the serosa (P = .02 and .05 respectively). All groups showed an increase in caspase- and calprotectin-positive cells during reperfusion (P < .05). TUNEL-positive cells increased during ischaemia, followed by a decrease after reperfusion (P < .05).
The small sample size and the use of a historical control group. Preconditioning effects of the tested drugs may be masked by the protective effects of isoflurane in the anaesthetic protocol.
Preconditioning with lidocaine did not have any effect on the tested variables. The lower cell counts of caspase- and calprotectin-positive cells in group X may indicate a beneficial effect of xylazine on ischaemia/reperfusion injury. Due to the absence of a concurrent reduction of histomorphological injury, the clinical significance remains uncertain.
在不同的动物模型中,包括马,已报道右美托咪定的药理学预处理对小肠缺血/再灌注损伤有保护作用。
本研究旨在评估马专用麻醉剂二甲噻嗪和利多卡因是否对马空肠缺血模型具有预处理作用。
终末体内实验。
10 匹全麻马分为二甲噻嗪预处理组(X 组,n=5)、利多卡因预处理组(L 组,n=5)和未处理对照组(C 组,n=5)。建立马空肠缺血模型,在缺血前、缺血后和再灌注后采集肠组织样本。根据改良 Chiu 评分进行组织形态学检查。进行 cleaved caspase-3、TUNEL 和钙卫蛋白免疫组化染色,并以细胞/mm 表示阳性细胞计数。
从缺血到再灌注,组织形态学黏膜损伤没有进展,组间组织学无差异。与对照组相比,X 组缺血后 caspase 阳性细胞数明显减少,中位数差异为 227%(P=.01)。再灌注后,X 组黏膜和浆膜 calprotectin 阳性细胞计数明显低于对照组,中位数差异分别为 6.8 个细胞/mm 和 44 个细胞(P=.02 和.05)。所有组在再灌注期间 caspase 和 calprotectin 阳性细胞数均增加(P<.05)。TUNEL 阳性细胞在缺血期间增加,再灌注后减少(P<.05)。
样本量小和使用历史对照组。在麻醉方案中使用异氟烷可能会掩盖测试药物的预处理作用。
利多卡因预处理对测试变量没有影响。X 组 caspase 和 calprotectin 阳性细胞计数较低可能表明二甲噻嗪对缺血/再灌注损伤有有益作用。由于组织形态学损伤没有同时减少,其临床意义仍不确定。